These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 114335)

  • 1. [Genetic control by the HLA region of the immune response to factor VIII in hemophilic patients].
    Nuñez-Roldan A; Arnaiz-Villena A; Nuñez-Ollero G
    C R Seances Acad Sci D; 1979 Jun; 288(23):1719-20. PubMed ID: 114335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibody.
    Frommel D; Allain JP; Saint-Paul E; Bosser C; Noël B; Mannucci PM; Pannicucci F; Blombäck M; Prou-Wartelle O; Muller JY
    Thromb Haemost; 1981 Dec; 46(4):687-9. PubMed ID: 6800049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible linkage between the major histocompatibility complex and the immune response to factor VIII in classic haemophilia.
    Frommel D; Muller JY; Prou-Wartelle O; Allain JP
    Vox Sang; 1977; 33(5):270-2. PubMed ID: 919416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of major histocompatibility complex class II genes to inhibitor antibody formation in hemophilia A.
    Lippert LE; Fisher LM; Schook LB
    Thromb Haemost; 1990 Dec; 64(4):564-8. PubMed ID: 1982196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to inhibitor formation.
    Shapiro SS
    Prog Clin Biol Res; 1984; 150():45-55. PubMed ID: 6431441
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of factor VIII antibody in haemophilic monozygotic twins. European Study Group of Factor VIII Antibody.
    Scand J Haematol; 1979 Jul; 23(1):64-8. PubMed ID: 573920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII.
    Oldenburg J; Picard JK; Schwaab R; Brackmann HH; Tuddenham EG; Simpson E
    Thromb Haemost; 1997 Feb; 77(2):238-42. PubMed ID: 9157573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia A.
    Wieland I; Wermes C; Eifrig B; Holstein K; Pollmann H; Siegmund B; Bidlingmaier C; Kurnik K; Nimtz-Talaska A; Niekrens C; Eisert R; Tiede A; Ebenebe C; Lakomek M; Hoy L; Welte K; Sykora KW
    Hamostaseologie; 2008 Oct; 28 Suppl 1():S26-8. PubMed ID: 18958335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors in haemophilia: pathophysiology.
    Saint-Remy JM; Lacroix-Desmazes S; Oldenburg J
    Haemophilia; 2004 Oct; 10 Suppl 4():146-51. PubMed ID: 15479388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation.
    Bril WS; MacLean PE; Kaijen PH; van den Brink EN; Lardy NM; Fijnvandraat K; Peters M; Voorberg J
    Haemophilia; 2004 Sep; 10(5):509-14. PubMed ID: 15357778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR and Factor VIII antibodies in hemophilia A.
    Mayr WR; Lechner K; Niessner H; Pabinger-Fasching I
    Thromb Haemost; 1984 Apr; 51(2):293. PubMed ID: 6429887
    [No Abstract]   [Full Text] [Related]  

  • 12. Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodies.
    Aly AM; Aledort LM; Lee TD; Hoyer LW
    Br J Haematol; 1990 Oct; 76(2):238-41. PubMed ID: 2128808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic risk factors for inhibitors to factors VIII and IX.
    Oldenburg J; Pavlova A
    Haemophilia; 2006 Dec; 12 Suppl 6():15-22. PubMed ID: 17123389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigens in hemophiliacs A with or without factor VIII antibodies in a Venezuelan Mestizo population.
    Simonney N; De Bosch N; Argueyo A; Garcia E; Layrisse Z
    Tissue Antigens; 1985 Apr; 25(4):216-9. PubMed ID: 3925592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histocompatibility antigens and alleles in Japanese haemophilia A patients with or without factor VIII antibodies.
    Ohta H; Takahashi I; Kojima T; Takamatsu J; Shima M; Yoshioka A; Saito H; Kamiya T
    Tissue Antigens; 1999 Jul; 54(1):91-7. PubMed ID: 10458328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic basis of inhibitor development in haemophilia A.
    Tuddenham EG; McVey JH
    Haemophilia; 1998 Jul; 4(4):543-5. PubMed ID: 9873791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of immune response genes on the expression of disease.
    Stobo JD
    J Lab Clin Med; 1982 Dec; 100(6):822-8. PubMed ID: 6815287
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J; Borovok M; Bi L; Kazazian HH; Hoyer LW
    Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of inhibitors in mild/moderate haemophilia A.
    Peerlinck K; Jacquemin M
    Haemophilia; 2006 Dec; 12 Suppl 6():43-7. PubMed ID: 17123393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.